PacificHealth Laboratories – Trademark Portfolio
Entity Type: 03
PacificHealth Laboratories holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 15 filings in this category. The portfolio also extends into Class 32 (Light Beverages) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include 2ND SURGE. The owner is based in Matawan, NJ.
100 Matawan Road, Suite 420
Matawan, NJ 07747
Showing of trademarks Trademarks
Trademark Classifications
PacificHealth Laboratories's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does PacificHealth Laboratories have?
PacificHealth Laboratories has 16 U.S. trademarks filed with the USPTO. Of these, 1 registered, 12 abandoned, 3 cancelled.
What trademark classes does PacificHealth Laboratories file in?
PacificHealth Laboratories files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 32 (Light Beverages), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are PacificHealth Laboratories's most well-known trademarks?
PacificHealth Laboratories's registered trademark portfolio includes well-known marks such as 2ND SURGE. These are among 1 currently registered trademark in the portfolio.
What is PacificHealth Laboratories's trademark registration success rate?
PacificHealth Laboratories has a 6% trademark registration rate, with 1 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.